Feb 28, 2020Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME studyPresented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.
Feb 28, 2020Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug usersGlecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the GRAND PLAN study Presented at the...
Feb 28, 2020Overdose events among active drug users successfully treated for HCV: the impact of homelessness.Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.